Shopping Cart
- Remove All
- Your shopping cart is currently empty
IDR-1018 acetate is an innate defense regulator conjugate with a minimum inhibitory concentration (MIC) of 16 μg/mL against MRSA USA300 LAC, MRSA SAP 0017, and S. epidermidis ATCC14990. It serves a role in the synthesis of V-IDR1018 (vancomycin-innate defense regulator conjugate).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | IDR-1018 acetate is an innate defense regulator conjugate with a minimum inhibitory concentration (MIC) of 16 μg/mL against MRSA USA300 LAC, MRSA SAP 0017, and S. epidermidis ATCC14990. It serves a role in the synthesis of V-IDR1018 (vancomycin-innate defense regulator conjugate). |
In vitro | IDR-1018 acetate modulates the expression of adhesion and activation markers in neutrophils. It is currently the most effective inducer of chemokines and demonstrates both anti-infective and anti-inflammatory properties in mouse models, showing therapeutic efficacy against Plasmodium berghei ANKA cerebral malaria, especially when used in conjunction with standard first-line antimalarial drugs. |
Formula | C71H126N26O12.xC2H4O2 |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.